The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors for recurrence in each pattern after curative gastrectomy for pStage II/III gastric cancer: An exploratory analysis of a randomized controlled trial (JCOG1001).
 
Tetsuro Toriumi
Stock and Other Ownership Interests - Pfizer
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yuya Sato
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; MC Medical; Medtronic; Nippon Kayaku; Olympus; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Intuitive Surgical (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Shuji Takiguchi
No Relationships to Disclose
 
Yuichiro Doki
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; MSD; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Yasuyuki Kawachi
No Relationships to Disclose
 
Hisashi Shinohara
No Relationships to Disclose
 
Yasuhiro Choda
No Relationships to Disclose
 
Seiji Ito
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Takeshi Sano
Speakers' Bureau - Johnson & Johnson; Medtronic; Ono Pharmaceutical; Taiho Pharmaceutical
 
Mitsuru Sasako
Honoraria - Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical